Baxter International Inc., together with a San Diego biotech company, have issued a voluntary recall of Hylenex after discovering small “flake-like glass particles” in some vials, The Chicago Tribune reports.
This recall of Hylenex comes less than a year after it was launched as a new way to rehydrate young patients with intravenous fluids. Hylenex works in a way that allows fluids to be administered under the skin, or subcutaneously, instead of the conventional IV method, the Chicago Tribune reports.
Though no injuries or customer complaints have been reported, the recall under way as a “precautionary measure due to instances of particulate matter observed in a limited number of Hylenex vials during routine stability testing”, Baxter spokesperson said.
According to Baxter statements, there are about 3,500 vials on the US market.
